Stocks360

American Shared Hospital Services (AMS)

Stock analysis · AMEX · Healthcare · Medical - Care Facilities

Share: Facebook X WhatsApp SMS
$1.25

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$8.31M
PE (TTM)
-4.95
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
0.29
Day Range
$1.25 – $1.28
52-wk Range
$1.21 – $2.39
Avg Volume
N/A
Volume
4.16K

American Shared Hospital Services (AMS) is a publicly traded company in the Healthcare sector. Latest price: $1.25. Market cap $8.31M. Trailing PE -4.95. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-27 · $2.20 2026-10-26 · $1.25 (-43.18%)

Earnings

Most Recent
Aug 13, 2026
EPS $-0.07 vs est. $-0.02
Missed by $0.05
Next Earnings
Nov 12, 2026
EPS estimate $0.01

Proprietary Signals

Signal snapshot temporarily unavailable.

About American Shared Hospital Services

American Shared Hospital Services specializes in leasing advanced radiosurgery and radiation therapy equipment to healthcare providers. The company offers Gamma Knife stereotactic radiosurgery systems, a non-invasive technology used to treat conditions such as malignant and benign brain tumors, arteriovenous malformations, and trigeminal neuralgia. They also facilitate financing for Leksell Gamma Knife units. Additionally, the firm operates proton beam radiation therapy centers in Orlando, Florida, and Long Beach, California. Customers further benefit from comprehensive support encompassing planning, installation, reimbursement guidance, and marketing strategies. As of December 31, 2021, their portfolio included 115 active Gamma Knife units across the United States, complemented by two units in South America (Lima, Peru, and Guayaquil, Ecuador), and one proton beam radiation therapy system. Established in 1980, American Shared Hospital Services maintains its headquarters in San Francisco, California.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)-4.95×
P/S (TTM)0.27×
P/B0.37×
P/FCF (TTM)2.35×
EV / EBITDA7.20×
EV / Sales0.73×
Earnings Yield-20.65%
Free Cash Flow Yield42.53%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value$22.32M
Revenue (TTM)$30.41M
Net Income (TTM)-$1.72M
Free Cash Flow (TTM)$4.57M
Net Debt$14.01M
Working Capital-$5.06M
Gross Margin17.10%
Operating Margin-8.43%
Net Margin-5.83%
Return on Equity-7.45%
Return on Invested Capital-5.52%

Peers

Recent News

Related

Browse more tickers: sitemap